Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: The role of biologic variation in the interpretation of results

This publication has 31 references indexed in Scilit:

• BNP‐Guided Therapy Not Better Than Expert's Clinical Assessment for β‐Blocker Titration in Patients With Heart Failure
  Congestive Heart Failure, 2005
• Effect of Compensated Renal Dysfunction on Approved Heart Failure Markers
  Hypertension, 2005
• Quality Specifications for Imprecision of B-Type Natriuretic Peptide Assays
  Clinical Chemistry, 2005
• Clinical Relevance of Biological Variation of B-Type Natriuretic Peptide
  Clinical Chemistry, 2005
• The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) study
  The American Journal of Cardiology, 2005
• Biomarker Responses during and after Treatment with Nesiritide Infusion in Patients with Decompensated Chronic Heart Failure
  Clinical Chemistry, 2005
• Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction
  The American Journal of Cardiology, 2004
• Optimum blood collection intervals for B-type natriuretic peptide testing in patients with heart failure
  The American Journal of Cardiology, 2004
• Analytical and Clinical Evaluation of the Bayer ADVIA Centaur Automated B-Type Natriuretic Peptide Assay in Patients with Heart Failure: A Multisite Study
  Clinical Chemistry, 2004
• Effect of Beta-Blocker on Left Ventricular Function and Natrituretic Peptides in Patients With Chronic Heart Failure Treated With Angiotensin-Converting Enzyme Inhibitor
  Japanese Circulation Journal, 2000